2019 Cannabis Business Award's
Publication of the Year |
REGISTER FOR TONIGHTS' SPECIAL LEGISLATIVE UPDATE MEETING OF THE "FLORIDA MEDICAL CANNABIS
PHYSICIAN GROUP" (FMCPG) FOR ALL "MEDICAL MARIJUANA DOCTORS"
AND "MMTC DIRECTORS ONLY "
SIGN UP TODAY
TOPICS TO BE DISCUSSED FOLLOW UP ON RECENT DEVELOPMENTS ON 2023 LEGISLATIVE ISSUES FROM OUR MARCH 29 MEETING WHAT CAN HURT YOUR PRACTICE
UPDATE FROM TALLAHASSEE ON TELEHEALTH BILL FOR CANNABIS PATIENTS
UPDATE FROM TALLAHASSEE ON THE HEMP BILL
PROTECTING YOUR MEDICAL CANNABIS PRACTICE CHANGES FROM THE OMMU - NEW MMTCs
QUESTIONS FROM PHYSICIANS HOW TO BEST ANSWER YOUR PATIENT QUESTIONS CLICK HERE TO REGISTER FOR THE APRIL 5 MEETING |
NEWS FROM THE PAST WEEK RELATING TO THE BUSINESS OF CANNABIS IN FLORIDA Click on Company Logo to be Transferred to Web Site |
INSA CANNABIS LAUNCHES INAUGURAL MULTISTATE ‘INSA FLOWER POWER’ SWEEPSTAKES Cannabis Patients and Consumers Feeling Lucky Have the Chance to Celebrate 4/20 with $5,000!
CHICOPEE, MA – April 3, 2023 – Insa, Inc., an independent, Massachusetts-based medical and adult-use cannabis company, is excited to announce the launch of their first-ever, multistate sweepstakes: ‘Insa Flower Power.’ As the marquee cannabis holiday, 4/20, quickly approaches, Insa is putting a “flower-forward” spin on the classic sweepstakes model. The ‘Insa Flower Power’ sweepstakes is a new way to drive customer traffic and brand engagement at both Insa’s retail locations as well as select Insa retail partners’ brick and mortar stores.
Kicking off earlier this month and running until April 11, 2023, adult-use consumers and medical patients can enter each week for a chance to win $100. At the conclusion of the weekly contests, the numerous $100 winners are automatically entered into the final drawing for a chance to win the $5,000 Grand Prize on 4/20.
For those looking to get in on the action, Insa has made it simple to participate in the sweepstakes fun! First, visit one of Insa’s retail locations in Massachusetts and/or Florida, or a participating Massachusetts partner retailer (The Healing Center, Cannabis Connection, Collective Cannabis and 1 Connection.) Second, scan the QR code at the register, fill out your information, and submit – No purchase is necessary. Insa also helps maximize the chances to win by doubling entries for all who sign up for the Insa Insider Loyalty program. Interested participants can also enter via mail (see Official Rules for instructions) and must reside in either Connecticut, Florida, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, or Vermont – and be of legal consumption age at time of entry.
READ MORE
|
COLUMBIA CARE EXTENDS MATURITY OF 13% SENIOR SECURED NOTES TO MAY 2024
March 28, 2023– Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today announced that it has provided notice to extend the maturity of its 13% senior secured notes (the “2023 Notes”) in the amount of $38.2 million, originally due on May 14, 2023, by twelve months. READ MORE
|
COLUMBIA CARE REPORTS FOURTH QUARTER AND FULL YEAR 2022 RESULTS Record Annual Revenue of $511.6 Million, an Increase of 11% YoY Record Annual Gross Profit of $201.2 Million, an increase of 4% YoY
Record Annual Adjusted EBITDA1 of $67.4 Million, an Increase of 17% YoY
and Annual Adjusted EBITDA Margin1 of 13%, an Increase of 60bps YoY
NEW YORK–March 29, 2023– Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today reported its financial and operating results for the fourth quarter and full year ended December 31, 2022. All financial information presented in this release is in U.S. GAAP and in thousands of U.S. dollars, unless otherwise noted.
“Columbia Care achieved record financial results again in 2022, as we continued to build scale and optimize our portfolio of assets within our strategically diverse retail footprint. Despite cyclicality in the fourth quarter coinciding with ongoing macroeconomic headwinds that impacted both the consumer, and in particular, wholesale market pricing, topline revenue grew to more than $511 million, up 11% over 2021, and we improved our Adjusted EBITDA margin by 60 basis points during that same time period. Our strategic position in the fastest growing markets in the country continues to drive revenue and earnings growth, as we see an increasing contribution from markets such as New Jersey and Virginia,” said Nicholas Vita, CEO of Columbia Care.
READ MORE |
COLUMBIA CARE OPENS FIFTH CANNABIST DISPENSARY IN WEST VIRGINIA Cannabist Huntington is Company’s 84th Active Dispensary Nationwide
NEW YORK–Mar. 31, 2023– Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today announced it has opened its fifth dispensary in West Virginia. This is also the Company’s 34th Cannabist location in the U.S. Cannabist Huntington is located at 917 3rd Avenue and is now serving registered medical patients.
READ MORE
|
AYR WELLNESS ANNOUNCES LEADERSHIP UPDATE
MIAMI, April 04, 2023 — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator (“MSO”), today announced that, effective immediately, Jen Drake has, on mutually agreed terms, resigned and stepped down from her role as chief operating officer.
“I am incredibly proud to have helped build AYR from an idea in 2018 to a 2,500-person organization today,” said Jennifer Drake. “The commitment and passion of the AYR team will be an inspiration to me as I take on my next challenge, which I can do with confidence knowing that AYR is in the hands of David Goubert’s leadership.”
READ MORE
|
CURALEAF ANNOUNCES ACQUISITION OF DESERET WELLNESS Transaction Strengthens Curaleaf’s Presence in Utah as State’s Largest Retail Operator Upon Close, the Company’s Retail Footprint Will Increase to Four Dispensaries in Utah and 150 Nationwide
NEW YORK, March 29, 2023 — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer cannabis products, today announced that it has entered into a definitive agreement to acquire Deseret Wellness (“Deseret“), the largest cannabis retail operator in Utah, in a cash and stock transaction valued at approximately US$20 million (the “Transaction”). The Transaction is expected to close imminently, subject to customary closing conditions.
The proposed Transaction with Deseret includes three retail dispensaries located in the cities of Park City, Provo and Payson, with a combined annualized revenue run rate of US$14 million. Deseret immediately strengthens Curaleaf’s retail footprint in Utah, providing the state’s medical patients with a wide variety of quality products including cannabis flower, vape cartridges, edibles, and concentrates. Following the close of Deseret, Curaleaf’s retail footprint will increase to four dispensaries in Utah and 150 nationwide.
READ MORE |
NEW NAME HOUSE OF PLATINUM CANNABIS |
VERANO REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS
Company Delivers Record Revenue of $879 Million, a 19% Year-Over-Year Increase CHICAGO, March 30, 2023 — Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced its financial results for the fourth quarter and year ended December 31, 2022, which were prepared in accordance with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”).
Management Commentary
“I’m very proud of our results in 2022, highlighted by record revenue and one of the industry’s leading margin profiles, which demonstrate our continued execution in driving efficiencies across the business and positioning ourselves ahead of growth,” said George Archos, Verano Founder, Chairman and Chief Executive Officer. “Since the end of 2021, we grew our retail footprint by adding more than 30 dispensaries across multiple core markets, significantly expanded our brand portfolio by launching a number of differentiated products that cater to a variety of consumers, celebrated the launch of adult use sales across our East Coast footprint in New Jersey and Connecticut, refinanced debt in a rising rate environment to include optionality, and made strategic investments to drive greater efficiencies across the business. Our products also continued to gain popularity with patients and consumers, demonstrated by an increased sell-through rate of Verano-branded products that have elevated our brands into top positions across many core markets, including our leading position in New Jersey.”
“From a policy perspective, while we’re disappointed in the lack of substantive legislative or banking reforms which will place additional pressure on many industry operators, we’re encouraged by continued momentum in support of cannabis at the state level and progressive conversations at the federal level,” Archos continued. “Our strategy since inception has been focused on establishing a self-sustaining business regardless of macroeconomic factors and legislative reforms, and we will continue to stay engaged with policymakers and be ready to take advantage of any future reforms at the federal level. In 2023, we will consider selective opportunities to further expand our footprint, focus on free cash flow generation, and leverage our leading position in markets that are poised for adult use transition in the near future, including Maryland. I am proud of what we’ve accomplished in just two years since our IPO, and remain excited and confident in our plans to drive long-term, sustainable growth.”
READ MORE
|
VERANO OPENS ZEN LEAF BUCKHANNON, THE COMPANY’S FIFTH WEST VIRGINIA DISPENSARY AND 126TH RETAIL LOCATION NATIONWIDE Zen Leaf Buckhannon is located at 120 Buckhannon Crossroads near U.S. Route 119, a busy highway with an average daily traffic count of up to 50,000 vehicles1 Zen Leaf Buckhannon is the first medical cannabis dispensary in Buckhannon and Upshur County, an area with a population of over 23,0002
ispensaries and 14 cultivation and processing facilities with more than 1 million square feet of cultivation capacity
CHICAGO, March 31, 2023 — Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the opening of Zen Leaf Buckhannon on Friday, March 31, 2023; this is the Company’s fifth West Virginia dispensary and 126th retail outlet nationwide. Zen Leaf Buckhannon, located at 120 Buckhannon Crossroads, is open Wednesday through Saturday from 11 a.m. to 7 p.m. and Sunday from 10 a.m. to 4 p.m., local time. Zen Leaf Buckhannon joins Verano’s four additional West Virginia Zen Leaf locations in Clarksburg, Morgantown, Westover and Wheeling. According to West Virginia’s Office of Medical Cannabis, there are currently over 23,000 approved medical cannabis patients in the state.
READ MORE
|
IANTHUS REPORTS FISCAL FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS
NEW YORK and TORONTO, March 29, 2023 – iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN) (OTCPK: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, today reported its financial results for the fourth quarter and year-ended December 31, 2022. The Company’s Annual Report on Form 10-K (the “Annual Report”), which includes its audited consolidated financial statements for the year-ended December 31, 2022 and the related management’s discussion and analysis of financial condition and results of operations, can be accessed on the Securities and Exchange Commission’s (“SEC’s”) website at www.sec.gov, the Company’s SEDAR profile at www.sedar.com, and on the Company’s website at www.iAnthus.com. The Company’s financial statements are reported in accordance with U.S. generally accepted accounting principles (“GAAP”). All currency is expressed in U.S. dollars.
2022 Financial Highlights Revenue of $163.2 million, down 19.6% from the prior year. Gross profit of $74.4 million, down 32.0% from the prior year. Gross margin of 45.6%, reflecting a decrease of 8.3% from the prior year.
Net loss of $449.4 million, or a loss of $0.13 per share, compared to a loss of $77.5 million, or a loss of $0.45 per share, in the prior year. Adjusted EBITDA(7) of $4.0 million, down from $36.2 million from the prior year. EBITDA and Adjusted EBITDA are non-GAAP measures. Reconciliation tables of EBITDA and Adjusted EBITDA as used in this news release to GAAP are included below.
READ MORE
|
NATIONAL AND INTERNATIONAL NEWS |
MARIMED RECEIVES APPROVAL TO ONCE AGAIN PRODUCE AND SELL HIGH-DOSAGE EDIBLES IN MARYLAND
NORWOOD, Mass., April 04, 2023 — MariMed Inc. (CSE: MRMD), (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator, today announced that its wholly owned subsidiary, Kind Therapeutics USA, has received approval from the Maryland Medical Cannabis Commission (“MMCC”) to immediately begin producing and distributing higher-dosage, THC-infused edibles. Maryland cannabis regulations changed in 2021, imposing a THC limit of 10 milligrams per edible serving unless the product was produced and distributed from a Good Manufacturing Practice (“GMP”) certified kitchen.
GMP certification is a process conducted by third-party auditors that ensures a commercial kitchen and the products created there meet the highest standards for health and safety. When the Company’s Hagerstown, Maryland, production kitchen secured GMP certification recently, MariMed immediately applied for and yesterday received approval from the MMCC to once again produce and distribute its very popular high-dosage products in the state. The Company plans to add 40mg products across its entire edibles portfolio very soon, beginning immediately with Betty’s Eddies fruit chews in the coming weeks.
READ MORE
|
CLEVER LEAVES REPORTS FOURTH QUARTER AND FULL YEAR 2022 RESULTS – Fourth Quarter and Full Year 2022 Cannabinoid Revenue Increased 71% and 90%, Respectively; Total Annual Revenue Growth was 16% Year-over-Year – – Steady Cost Reductions and Portugal Wind-Down Expected to Drive Production, Cost, and CapEx Efficiencies –
– Announces Financial Outlook and Key Focus Markets for 2023 –
TOCANCIPÁ, Colombia, March 30, 2023 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, is reporting financial and operating results for the fourth quarter and full year ended December 31, 2022. All financial information is provided in US dollars unless otherwise indicated.
“2022 was a transformational year for Clever Leaves as we executed on our refined growth strategy,” said Andres Fajardo, CEO of Clever Leaves. “Our full year revenue growth exceeded our revised 2022 guidance target, reflecting the commercial traction we have gained across our target markets in our cannabinoid business, which grew 90% in 2022. We have also steadily streamlined our cost structure throughout the year, driving a 30% year-over-year decrease in our G&A expenses and sales and marketing costs combined. Similarly, our capital expenditures decreased by 82% in 2022 compared to 2021. This progress allowed us to perform in line with our revised 2022 financial outlook across our key metrics, even as we navigated ongoing revenue headwinds from broader macroeconomic pressures within our non-cannabinoid segment. As we move further into 2023, I believe we are positioned to continue executing on our growth objectives from a leaner, more efficient operational foundation.”
READ MORE
|
JUSHI HOLDINGS INC. REPORTS UNAUDITED, PRELIMINARY FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS Q4 2022 Revenue Increased 16.6% YoY to $76.8 million and FY 2022 Revenue Increased 35.8% to a Record $284.3 million Solidified Retail Network with Seven New Store Openings and 35 Operational Dispensaries Nationwide in 2022
BOCA RATON, Fla., March 31, 2023 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, is pleased to announce its unaudited preliminary financial results for the fourth quarter (“Q4 2022”) and full year ended December 31, 2022 (“FY 2022”). All financial information is provided in U.S. dollars unless otherwise indicated and is prepared under U.S. Generally Accepted Accounting Principles (“GAAP”).
Financial Highlights
Q4 2022
Total revenue of $76.8 million, an increase of 16.6% year-over-year and 5.5% sequentially Gross profit of $22.0 million, an increase of 11.4% year-over-year Net loss of $139.9 million Adjusted EBITDA1 of $6.0 million
Reduced inventory by $7.0 million versus the prior quarter Cash, cash equivalents and restricted cash were $27.1 million
READ MORE
|
UNRIVALED BRANDS REPORTS PRELIMINARY FOURTH QUARTER 2022 FINANCIAL RESULTS Company Reports Preliminary Net Profit From Operations of $8.8 Million in Q4 2022 Versus Net Loss of $13.3 Million in Q4 2021
SANTA ANA, Calif., March 29, 2023 (– Unrivaled Brands, Inc. (OTCQB: UNRV) (“Unrivaled” or the “Company”), a cannabis company with operations throughout California, announces preliminary quarter ending December 31, 2022 financial results.
Preliminary Q4 2022 Highlights
Operating profit for the quarter-ended December 31, 2022, was $8.8 million compared to a Q4 net loss of $13.3 million in 2021, an increase of $22.1 million.
During the quarter-ended December 31, 2022, total liabilities were reduced by $50.2 million to $75.2 million, down from $125.4 million at the end of the prior year; a reduction of 40%. This decrease was the result of successful efforts to renegotiate debt, pay down creditors, dispose of non-performing assets and improve working capital.
In December 2022, Unrivaled entered into a Management Services Agreement with Brick City Productions, Inc. to reopen and manage the Company’s Blüm San Leandro dispensary.
During the quarter-ended December 31, 2022 the Company entered into two binding Letters of Intent (each an “LOI”) to operate Cookies-branded dispensaries: (i) an LOI with 510 Retail & Events, Inc. to operate a Cookies-branded dispensary in Oakland, California and (ii) a second LOI with Green Door Redding, LLC to operate a Cookies-branded dispensary in Redding, California.
READ MORE
|
SWEET LEAF MADISON CAPITAL SECURES $100 MILLION FINANCING FACILITY
Ongoing industry funding challenges driving need for alternative sources of capital, increasing demand for debt financing for the middle market
DENVER, March 30, 2023 — Sweet Leaf Madison Capital (“SLMC” or “Sweet Leaf Madison”), a nationwide provider of tailored debt financing solutions in real estate, equipment and senior secured working capital for the compliant middle-market cannabis industry, today announced the closing of a new $100MM debt facility. A prominent New York-based global institutional special situations asset manager will be providing $100MM of financing, making SLMC one of the best-financed asset-based lenders to small- and medium-sized enterprises in the cannabis industry. Both parties will have an option to evaluate the progress and increase the debt facility to $200MM.
READ MORE
|
TREEZ ANNOUNCES ENTRY INTO ILLINOIS WITH CLOUD 9 CANNABIS DISPENSARY AND INTEGRATION WITH BIOTRACK
SAN FRANCISCO, April 04, 2023 — Treez, the leading enterprise commerce technology platform that streamlines retail and supply chain operations within the cannabis industry, today announced its entrance into Illinois with Cloud 9 Cannabis (Cloud 9) dispensary and an integration with BioTrack, the official Illinois state cannabis traceability system. Treez integration with BioTrack enables the Company to provide services in states mandating the use of BioTrack for seed-to-sale tracking and government reporting.
“We’re starting the year off strong by delivering on our promise to bring Treez to more states in 2023. Our integration with BioTrack has enabled us to enter the state of Illinois as Cloud 9 Cannabis’ exclusive retail software provider,” said John Yang, CEO of Treez. “We are excited to launch in Illinois with Cloud 9 and look forward to delivering an experience that improves the way they acquire, engage and retain customers through the use of our point-of-sale solutions and data and analytics capabilities.”
READ MORE
|
RUBICON ORGANICS REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS Achieved Adjusted EBITDA1 of $1.9 million for the year ended December 31, 2022 57% net revenue growth to $35.5 million in 2022 compared to 2021 Achieved operating cash flow of $2.0 million for the year ended December 31, 2022 6.3%2 national market share of premium flower and pre-rolls in 2022
VANCOUVER, British Columbia, April 03, 2023– Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics”, “Rubicon”, or the “Company”), a licensed producer focused on cultivating and selling organic certified, premium cannabis, today reported its financial results for the fourth quarter and year ended December 31, 2022 (“Q4 2022”). All amounts are expressed in Canadian dollars.
READ MORE
|
DELTA 9 REPORTS YEAR-END FINANCIALS FOR 2022
WINNIPEG, Manitoba, March 31, 2023 — DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: DLTNF) (“Delta 9” or the “Company”) is pleased to announce financial and operating results for the three-month and full year ending December 31, 2022. Financial Highlights for the Year Ending December 31, 2022
Net revenues of $63.2 million in 2022, an increase of 2% compared to $62.3 million in 2021, including the following revenue segmentation highlights: Retail revenues increased 26% to $52.2 million in 2022 Wholesale revenues decreased 35% to $12.1 million in 2022 Business to business revenues decreased 65% to $1.7 million in 2022 Gross profit1 of $12.9 million in 2022 compared to $18.3 million last year.
Adjusted EBITDA2 (loss) of $(5.2) million in 2022 compared to an Adjusted EBITDA2 of $2.0 million last year. Loss from Operations of $(20.3) million in 2022 compared to Loss from Operations of $(7.6) million last year.
READ MORE |
COLOMBIAN CANNABIS COMPANY ULTIMATE SPORTS, INC./SANNABIS (OTC: USPS) DEVELOPS PURPLE RAIN VARIETY TERPENE SPRAY TO ENTER THE CANNABIS NUTRACEUTICAL INDUSTRY THAT IS EVOLVING FROM CBD TO TERPENES. Sannabis’ Holy Essence Purple Rain Terpene Spray, is available in Colombia and expected to be on shelves in the U.S. this Summer.
Cali-Colombia, March 31, 2023 – Ultimate Sports, Inc. (OTC: USPS) (the ‘Company’), a Men’s Health services provider in the U.S that recently acquired Colombian cannabis company, Sannabis S.A.S.(‘Sannabis’), is proud to announce the launch of its new cannabis terpene spray. This spray enhances the nutraceutical value of a user’s daily intake of food and beverages. Currently it is being prescribed by doctors in Colombia as part of their patient’s medicinal cannabis treatment.
Sannabis Terpenes are designed for food and beverage applications to enhance both flavor and therapeutic benefits. The spray is added to provide a unique sensory and therapeutic experience with pharmaceutical health benefits. With the rising popularity of cannabis and its derivatives, consumers are increasingly seeking new and innovative ways to experience the benefits of this versatile plant.
Sannabis’ new terpene spray harnesses the power of cannabis terpenes to create unique and memorable scents and flavors that can be enjoyed in a variety of settings.
READ MORE
|
LOWELL FARMS INC. ANNOUNCES AUDITED FOURTH QUARTER AND FISCAL YEAR 2022 FINANCIAL AND OPERATIONAL RESULTS
SALINAS, Calif., March 30, 2023 (GLOBE NEWSWIRE) — Lowell Farms Inc. (the “Company”) (CSE: LOWL; OTCQX: LOWLF), a California-born vertically integrated cannabis company with advanced production capabilities including cultivation, extraction, manufacturing, and distribution, announces audited revenue and operating results for the fourth quarter and fiscal year (ended December 31, 2022). All figures stated are in US Dollars. Fourth Quarter and Fiscal Year Financial Highlights:
Revenue generated for the quarter ended December 31, 2022, was $9.3 million; a decrease of 38% from the fourth quarter last year and a 7% sequential increase from the third quarter of 2022.
Revenue for the year ended December 31, 2022 was $43.5 million.
Sales of self-grown bulk wholesale products increased 42% sequentially to $2.8 million during the quarter including a 23% increase in volume and a 7% increase in realized price per pound.
READ MORE
|
BELOW ARE THE LINKS TO THE DIRECTORY OF FLORIDA CANNABIS DOCTORS AND DISPENSARIES IN THE STATE OF FLORIDA |
CANNABIS NEWS FLORIDA APRIL 2023 SPOTLIGHT PAULA SAVCHENKO, ESQ. – FOUNDER OF CANNACORE GROUP APRIL 2023 |
We are a full-service cannabis and psychedelic licensing company specializing in helping businesses enter new markets to achieve their long-term goals. Cannacore Group has more than 19 years of combined knowledge and experience in the Cannabis Business Application Process. From Florida to California, we have achieved continuous success in obtaining cannabis business licenses with an 85% success rate! What do we do? Work with lobbyists and advocates to work toward nationwide cannabis legalization. Collaborate and advise groups on how to achieve their goals in attaining cannabis business licenses in new and expanding markets.
Identify new markets to target, put together an all-encompassing business plan, and bring in additional resources as needed, including funding and an operational team. Provide proven Standard Operating Procedures included in the application process as well as after attaining the license.
It is important to have proper guidance while navigating, entering or operating in the cannabis industry. Whether you need an expert to help you enter the industry or if you are already an operational business in the space and need consultation, we are here to lead the way. We handle each step of the Cannabis Business Licensing process. From working with your team to identifying new market opportunities, putting together a strong team using our expansive network, drafting a thorough application, challenging agency action (if needed), business structuring, tax planning, and consulting to keep your business compliant and successful.
READ MORE |
QUALIFIED PATIENTS OVER 804,000 AND 551 DISPENSING LOCATIONS |
LATEST OMMU REPORTS FROM OFFICE OF MEDICAL MARIJUANA USE IN THE STATE OF FLORIDA Highlights from MARCH 31, 2023 Report BY THE NUMBERS Qualified Patients: (Active ID Card): MAR 31 2023- 804,066 MAR 24 2023- 802,251
MAR 17 2023- 800,356 MAR 10 2023- 797,505 MAR 03 2023- 794,779
Patients Last Week: 1,815 Qualified Ordering Physicians: 2,522 New Doctors Last Week: - 3 Reporting Period: MAR 24 - MAR 30, 2023
Amount of Medical Marijuana Dispensed - (mgs THC) 296,389,832 Amount of Low-THC Cannabis Dispensed - (mgs CBD) 2,931,659 Amount of Marijuana in a From for Smoking (oz) 101,093.804 Approved Dispensing Locations: 551 ADD LAST WEEK +2
GREEN DRAGON - SOUTH PASADENA JUNGLE BOYS - MIAMI BEACH |
UPCOMING MEETING AND CONFERENCES |
THE FLORIDA MEDICAL CANNABIS PHYSICIANS GROUP ANNUAL IN-PERSON MEETING WILL BE HELD AT THE FLORIDA MEDICAL CANNABIS CONFERENCE & EXHIBITION SEE INFORMATION BELOW FOR REGISTRATION |
ADVERTISEMENT OPPORTUNITIES
If your goal is to get your business in front of the right people in the cannabis industry or you want to be an integral part of this new and exciting business opportunity, then you need to join with Cannabis News Florida as we help to establish cannabis as a major part of the economy in Florida. Cannabis News Florida is an online publication focusing on both local and national news from leading authorities about the medical and business developments in the medical cannabis industry covering the entire state of Florida.
Join the Cannabis News Florida force online and in print. We offer several marketing options to fit all budgets:
· MMTC PROMOS LISTED IN EACH E-NEWSLETTER • Directory Listing • Banner Ads • Ad Space in the Newspaper • Feature Articles • Weekly Newsletters
For further information or to make your ad reservation, please call:561-368-6950 / 954-605-4785 cell charles@cannabisnewsflorida.com
|
|
|